BACTI_B: Infection prevention technology and MedTech partnerships drive growth and ambitious 2030 targets

About this update from Bactiguard Holding Ab

Strategic focus on MedTech partnerships and infection prevention technology drove revenue and EBITDA growth in 2024, with ambitious targets set for 2030. Addressable markets exceed USD 74 billion across key therapeutic areas.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Bactiguard Holding Ab